Publication:
Complications of metabolic acidosis and alkalinizing therapy in chronic kidney disease patients: a clinician-directed organ-specific primer

Simple item page
dc.contributor.coauthorSag, Alan A.
dc.contributor.coauthorAfsar, Baris
dc.contributor.coauthorRossignol, Patrick
dc.contributor.coauthorCovic, Adrian
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorResearcher, Çöpür, Sidar
dc.contributor.kuauthorFaculty Member, Kanbay, Mehmet
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T23:46:03Z
dc.date.issued2020
dc.description.abstractChronic kidney disease is prevalent, affecting more than one in ten adults. In this population, metabolic acidosis is considered a key underlying pathophysiological feature, tying together bone mineral disorders, sarcopenia, insulin resistance, vascular calcification, pro-inflammatory and pro-thrombotic states. This review aims to address the paucity of literature on alkalinizing agents, a promising treatment option that has known adverse effects
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue12
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume52
dc.identifier.doi10.1007/s11255-020-02563-2
dc.identifier.eissn1573-2584
dc.identifier.issn0301-1623
dc.identifier.quartileQ3
dc.identifier.scopus2-s2.0-85087887255
dc.identifier.urihttps://doi.org/10.1007/s11255-020-02563-2
dc.identifier.urihttps://hdl.handle.net/20.500.14288/13912
dc.identifier.wos548170700002
dc.keywordsChronic kidney disease
dc.keywordsEnd-stage renal disease
dc.keywordsMetabolic acidosis
dc.keywordsAlkaline treatment
dc.keywordsBicarbonate
dc.keywordsLeft-ventricular hypertrophy
dc.keywordsGlomerular-filtration-rate
dc.keywordsJoint consensus statement
dc.keywordsGrowth-factor 23
dc.keywordsInsulin-resistance
dc.keywordsVitamin-d
dc.keywordsSodium-bicarbonate
dc.keywordsPhosphate binders
dc.keywordsEndothelial dysfunction
dc.keywordsParathyroid-hormone
dc.language.isoeng
dc.publisherSpringer
dc.relation.ispartofInternational Urology and Nephrology
dc.subjectUrology
dc.subjectNephrology
dc.titleComplications of metabolic acidosis and alkalinizing therapy in chronic kidney disease patients: a clinician-directed organ-specific primer
dc.typeReview
dspace.entity.typePublication
local.contributor.kuauthorKanbay, Mehmet
local.contributor.kuauthorÇöpür, Sidar
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files

Collections

Publications without Fulltext